BCLI (BrainStorm Cell Therapeutics) Kompaniyaning sof foydasi

BrainStorm Cell Therapeutics (BCLI) kompaniyasining rasmiy ramzlari

Brainstorm Cell (BCLI) uchun risklar uning ALS terapiyasi uchun FDA tasdig'iga bog'liq, garchi yetarli likvidlik zaxirasi vaziyatni barqarorlashtirsa-da. Ushbu grafikda kompaniyaning hisobotdagi foydasi joriy dinamikani namoyish etadi, bunda 0.00 qiymati metrika darajasini aks ettiradi. Ishlab chiqarish va klinik operatsiyalarni autsorsing qilish orqali samaradorlik oshmoqda, tibbiyot markazlari bilan strategik sherikliklar esa ilmiy sinergiyani yaratib, birlashish risklarini kamaytirmoqda.

BCLI (Brainstorm Cell Therapeutics, Inc.) Sof foyda tarixi 04.07.2022dan 02.08.2025gacha

BrainStorm Cell Therapeutics (BCLI) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi BrainStorm Cell Therapeutics Inc.|BCLI - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor qiymati BrainStorm Cell Therapeutics Inc.|BCLI - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi ko'rsatkichlari:
Aksiyaning buxgalteriya qiymati BrainStorm Cell Therapeutics|BCLI - Balans kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati brainstorm-cell.com|BCLI - Kompaniyaning umumiy aktivlari
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Umumiy qarzning kapitalga nisbati koeffitsiyenti Brainstorm Cell|BCLI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi Brainstorm Cell Therapeutics Inc.|BCLI - Kompaniya qarzlari|Sof aktivlarga qarzlar BrainStorm Cell Therapeutics Inc.|BCLI - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli majburiyatlar miqdori BrainStorm Cell Therapeutics|Shoshilinch likvidlik brainstorm-cell.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
BCLI - Kompaniyaning sof foydasi
Kompaniyaning asosiy tahlili:BCLI - BrainStorm Cell Therapeutics Inc.
BrainStorm Cell Therapeutics Inc. seriyali mahsuloti

Ushbu ko'rsatkich barcha xarajatlardan keyin qolgan sof naqd pul hajmini aniqlaydi, bu esa fundamental tahlil doirasida rahbariyatning operatsion samaradorligini ob'yektiv o'lchash imkonini beradi. Brainstorm Cell (BCLI) kompaniyasining hisobotdagi sof foyda tendentsiyasi uning noyob hujayraviy platformalarining monetizatsiyasini aks ettiradi, bunda patent himoyasi va neyrodegenerativ kasalliklar terapiyasida muqobillarning yo'qligi barqaror kapital oqimi va yuqori uzoq muddatli marjalarni ta'minlaydi.

Muhim raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Sof foyda|Kompaniyaning sof foydasi RGC|Kompaniyaning sof foydasi Axsome Therapeutics, Inc. (AXSM)|ACAD (ACADIA Pharma) - Yakuniy foyda|Sof foyda XENE (Xenon Pharmaceuticals Inc)|Sof foyda Viking Therapeutics Corp VKTX|Supernus Pharmaceuticals - Sof foyda|Sof moliyaviy natija catalystpharma.com CPRX|Denali Therapeutics Inc. (DNLI) - Kompaniyaning sof foydasi|Kompaniya foydasi HRMY|Kompaniyaning sof foydasi Biohaven Pharmaceutical|Amylyx Corp (AMLX) - Sof moliyaviy natija|Sof daromad TRVI (Trevi Therapeutics)|Soliqlar to‘langandan keyingi foyda PRAX|Kompaniyaning sof foydasi Anavex Life Sciences Corp. AVXL|CeriBell Inc (CBLL) - Kompaniyaning sof daromadi|PRTA - Kompaniyaning sof foydasi|Yakuniy foyda ALEC (Alector, Inc.)|Annexon, Inc. (ANNX) - Kompaniyaning sof foydasi|Sof daromad Omeros|Sof daromad NGNE|ACIU: Yakuniy foyda|Sof foyda VYGR|Sof daromad Neumora Corp NMRA|Sof foyda SCLX (Scilex Holding Company)|tevogen.com (TVGN) - Kompaniyaning sof daromadi|ACOG - Kompaniyaning sof foydasi|CGTX: Kompaniyaning sof foydasi|Inhibikase (IKT) - Kompaniyaning sof foydasi|SAVA (Cassava Pharma) - Kompaniyaning sof foydasi|ASRT (Assertio Holdings) - Sof foyda|Kompaniyaning sof foydasi COYA|Sof foyda VTGN|Sof daromad ovidrx.com OVID|Kompaniyaning sof foydasi Acumen Pharma ABOS|CervoMed Corporation - Kompaniyaning sof foydasi|Alterity Therapeutics Ltd - Sof foyda|Sof moliyaviy natija Clene Inc. CLNN|pepgen.com (PEPG) - Kompaniyaning sof foydasi|Kompaniya foydasi JUNS|RLMD (Relmada) - Sof foyda|Kompaniyaning sof daromadi Annovis Bio Corporation ANVS|Sof daromad GRCE (Grace Therapeutics, Inc.)|Sof foyda fireflyneuro.com (AIFF)|Kompaniyaning sof foydasi Klotho Neurosciences KLTO|Yakuniy foyda NRSN|RVPH - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi MetaVia Inc|NRXS: Sof foyda|HSDT (Helius Medical Technologies) - Kompaniyaning sof foydasi|Kompaniyaning sof foydasi Passage Bio Inc.|NEUP: Yakuniy foyda|Sof foyda NERV|Sof foyda Athira Pharma Corp (ATHA)|Sof foyda ADXN (Addex Therapeutics)|Sof moliyaviy natija Alzamend Neuro Inc. (ALZN)|CYCN - Kompaniyaning sof foydasi|PTIX (Protagenic Therapeutics) - Kompaniya foydasi|pasitheaclinics.com (KTTA) - Kompaniyaning sof foydasi|CRGT - Sof moliyaviy natija|Sof daromad ATXI|CARA (caratherapeutics.com) - Soliqlar to‘langandan keyingi foyda|Kompaniyaning sof foydasi Chromocell Therapeutics Corp. (CHRO)|ELYM - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Intra-Cellular Therapies, Inc. ITCI|Yakuniy foyda LBPH|MRNS - Kompaniyaning sof foydasi|nkgenbiotech.com (NKGN) - Sof daromad|NRBO (NeuroBo Pharmaceuticals, Inc.) - Sof daromad|Sage Therapeutics Inc. - Yakuniy foyda|SNPX (Neurotrope) - Sof foyda|Sof daromad Trevena Inc (TRVN)|Sof foyda VIGL|WENA - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Cerevel Therapeutics, Inc. CERE